Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by fredgoodwinsonon Feb 13, 2020 7:14am

96 Views

Post# 30684412

RE:When the virus replicates, it blows the cancer cells....

Thanks Markky - CAVATAK.

In a small (9 PERSON) CANON Trial it achieved one complete response out of the three at the highest dose as a monotherapy so it would most likely be used as a combination therapy with the usual multiple instillations etc. that make TLD-1433 such an attractive alternative.

Bullboard Posts

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta